搜索临床试验以:任何 FDA 批准的 ALK 抑制剂
总计256477个结果
-
Takeda完全的非小细胞肺癌 | 间变性淋巴瘤激酶阳性美国
-
Washington University School of MedicineCase Western Reserve University; University of Health and Allied Sciences完全的
-
Ankyra Therapeutics, Inc招聘中
-
Encore Medical Inc.Bright Research Partners; Yale Cardiovascular Research Group招聘中
-
Johns Hopkins UniversityMerck Sharp & Dohme LLC完全的
-
Mayo ClinicMedical University of South Carolina; University of Maryland; University of Alabama at Birmingham 和其他合作者邀请报名
-
Beijing Kejing Biotechnology Co., Ltd.Beijing Kejing Biotechnology Corp.撤销
-
Jack Khouri尚未招聘多发性骨髓瘤 | 难治性多发性骨髓瘤 | 细胞因子释放综合征 | 免疫效应细胞相关神经毒性综合征美国
-
Johns Hopkins UniversityNational Institute of Neurological Disorders and Stroke (NINDS)招聘中
-
Cynthia West完全的
-
Johns Hopkins UniversityUniversity of Utah; Integra LifeSciences Corporation完全的
-
Abbott Medical Devices完全的
-
ImmunityBio, Inc.终止
-
The First Affiliated Hospital of Xiamen University招聘中
-
Otsuka Pharmaceutical Development & Commercialization...完全的
-
Midwest Center for Metabolic and Cardiovascular...Pharmavite LLC完全的
-
E. Peden, MDThe Methodist Hospital Research Institute招聘中
-
Mannkind CorporationJaeb Center for Health Research主动,不招人
-
Oussama WazniThe Cleveland Clinic; Biosense Webster, Inc.终止